Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Wada

Showing results (821-830 of 844) with videos related to

Pageof 85
Sort By:
The Japanese Journal of Antibiotics|May 1, 1997
[Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)]H Ikemoto, K Watanabe, T Mori, et al.
Journal of the Neurological Sciences|February 13, 2001
Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsyK Urakami, K Wada, H Arai, et al.
The Japanese Journal of Antibiotics|May 1, 1996
[Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)]H Ikemoto, K Watanabe, T Mori, et al.
The Japanese Journal of Antibiotics|February 1, 1996
[Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)]H Ikemoto, K Watanabe, T Mori, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 1, 1997
[Usefulness of 7 day therapy with cefluprenam in the management of respiratory tract infections]K Shimada, M Ohmichi, H Sasaki, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Alpha-keto amides as inhibitors of histone deacetylaseCarol K Wada, Robin R Frey, Zhiqin Ji, et al.
Journal of Medicinal Chemistry|January 5, 2002
Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitorsCarol K Wada, James H Holms, Michael L Curtin, et al.
Plos One|May 29, 2015
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory NeuroblastomaGiselle L Saulnier Sholler, Eugene W Gerner, Genevieve Bergendahl, et al.
Cancer Reports (Hoboken, N.J.)|March 31, 2022
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastomaJacqueline M Kraveka, Elizabeth C Lewis, Genevieve Bergendahl, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Pageof 85

Showing results (821-830 of 844) with videos related to

Sort By:
Pageof 85
The Japanese Journal of Antibiotics|May 1, 1997
[Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)]H Ikemoto, K Watanabe, T Mori, et al.
Journal of the Neurological Sciences|February 13, 2001
Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsyK Urakami, K Wada, H Arai, et al.
The Japanese Journal of Antibiotics|May 1, 1996
[Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)]H Ikemoto, K Watanabe, T Mori, et al.
The Japanese Journal of Antibiotics|February 1, 1996
[Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)]H Ikemoto, K Watanabe, T Mori, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 1, 1997
[Usefulness of 7 day therapy with cefluprenam in the management of respiratory tract infections]K Shimada, M Ohmichi, H Sasaki, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Alpha-keto amides as inhibitors of histone deacetylaseCarol K Wada, Robin R Frey, Zhiqin Ji, et al.
Journal of Medicinal Chemistry|January 5, 2002
Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitorsCarol K Wada, James H Holms, Michael L Curtin, et al.
Plos One|May 29, 2015
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory NeuroblastomaGiselle L Saulnier Sholler, Eugene W Gerner, Genevieve Bergendahl, et al.
Cancer Reports (Hoboken, N.J.)|March 31, 2022
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastomaJacqueline M Kraveka, Elizabeth C Lewis, Genevieve Bergendahl, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Pageof 85